Bruce Power and Isogen, a partnership between Kinectrics and Framatome, have completed the installation of Isogen's isotope production system (IPS) at Unit 7 of Bruce's CANDU nuclear power plant in Ontario, Canada, making it the first power reactor in the world with installed capability to produce lutetium-177. Lu-177 is a medical isotope used in the treatment of various cancers, such as neuroendocrine tumors and prostate cancer. In the future, this system will have the capability to produce other isotopes for medical uses, the companies said. In September 2021, Bruce Power announced that it had received approval from the Canadian Nuclear Safety Commission to begin the produc- tion of Lu-177 using Isogen's IPS. Production is expected to begin this year.
展开▼
